Satoru Watanabe
Kanazawa, 9208641, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
High-dose ¹³¹I-metaiodobenzylguanidine therapy in relapsed high-risk neuroblastoma: a descriptive analysis of clinical outcomes and associated factors.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 27, 2025
Enhancing radioactive iodine (RAI) incorporation in RAI-refractory differentiated thyroid cancer: current insights.
Journal: European thyroid journal
Published: October 07, 2024
Transthyretin amyloid cardiomyopathy disease burden quantified using 99mTc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: May 28, 2023
Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan.
Journal: Endocrine journal
Published: December 25, 2022
Diagnosis of Parkinson syndrome and Lewy-body disease using 123I-ioflupane images and a model with image features based on machine learning.
Journal: Annals of nuclear medicine
Published: April 04, 2022
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma.
Journal: Annals of nuclear medicine
Published: September 20, 2021
Prognostic factors for refractory pheochromocytoma and paraganglioma after 131I-metaiodobenzylguanidine therapy.
Journal: Annals of nuclear medicine
Published: August 11, 2021
Volumetric evaluation of 99mTc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: July 11, 2021
High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience.
Journal: Annals of nuclear medicine
Published: July 08, 2020
Diagnostic Use of Post-therapy 131I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma.
Journal: Diagnostics (Basel, Switzerland)
Published: July 06, 2020
High-dose 131I-metaiodobenzylguanidine therapy in patients with high-risk neuroblastoma in Japan.
Journal: Annals of nuclear medicine
Published: January 07, 2020
Utility of 123I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and Paraganglioma.
Journal: Asia Oceania journal of nuclear medicine & biology
Published: August 06, 2019
Last Updated: 09/26/2026